National reference center for gestational trophoblastic disease in France

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative focuses on the registration, monitoring, and treatment of women diagnosed with gestational trophoblastic disease (GTD) in France. The center operates on a multidisciplinary approach, allowing patients to remain under the care of their local physician while also accessing specialized treatment at the center. Approximately 850 new cases are registered annually, with 140 women receiving treatment, primarily through chemotherapy and surgery. The center collaborates with local expert teams to provide comprehensive care and support for patients diagnosed with various forms of trophoblastic disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients are eligible if they have a histologically proven trophoblastic disease, or a diagnosis of gestational trophoblastic neoplasia done on an abnormal evolution of hCG

Exclusion Criteria:

* none

Where it's running

• Centre des Maladies Trophoblastiques Centre Hospitalier Lyon Sud-Bâtiment 3B-2ème étage, 165 Chemin du Grand Revoyet
  Pierre-Bénite, France Recruiting

Study contacts

• Principal investigator: François Golfier, Pr — Centre National de Référence des maladies trophoblastiques Centre Hospitalier Lyon Sud - Hospices Civils de Lyon
• Study coordinator: François Golfier, Pr
• Email: francois.golfier@chu-lyon.fr
• Phone: (0)4 78 86 66 78

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• National multicenter cohort of molar pregnancy in China

  This project will see how often molar pregnancy turns into cancer and which clinical or pathological factors predict that, by following patients across multiple hospitals in China.

  Recruiting at 4 sites Obstetrics & Gynecology Hospital of Fudan University · Lanzhou, Gansu and 13 other locations · NCT07202728

• Treatment options for hydatidiform mole with lung nodules

  This study is testing different treatment options for patients with hydatidiform mole and lung nodules to see which approach works best for getting their hormone levels back to normal.

  Recruiting Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT03785574

• Blood viscosity in ARDS: a look at how thick the blood is

  This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07823296

• Virus interactions in hospitalized patients during winter seasons in Lyon

  This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.

  Recruiting Hospices Civils de Lyon · Lyon, Rhone · NCT07805590

• Surgical Use of Efanoctocog alfa in Hemophilia A Patients

  This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.

  Recruiting Hospices Civils de Lyon · Bron · NCT07723560

• Sleep quality and its determinants during the liver transplant pathway

  This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.

  Recruiting Hospices Civils de Lyon · Lyon · NCT07674355

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.